Pharmaceutical Contract Manufacturing. Technology Transfer

This section is devoted to the Contract Manufacturing of Pharmaceuticals at the facilities of independent producers, who are fully compliant with technological processes and Quality Control in accordance with client requirements

Types of Contractors

  • Manufacturers, who specialize only in Contract Manufacturing
  • Manufacturers, who produce their own brands along with Contract Manufacturing

Types of Contract Services

  • Full-cycle manufacturing
  • Performing only some of the manufacturing operations (ex. packaging)

InterChem from Ukraine localized its manufacturing at Viva Pharm in Kazakhstan

SLC InterChem (Odessa, Ukraine) localized, at the facilities of LLP Viva Pharm, a Kazakhstani company, the manufacturing of three medicinal products, which will be available in the market of Kazakhstan

Biocad comes to Egypt with an eye to the entire Middle Eastern market

Biocad, a Russian biotech company, plans to open its representative office in Egypt by the end of 2017
lonza building

Lonza bought Micro-Macinazione to keep up API development challenge

Lonza has acquired Micro-Macinazione, one of Europe’s leading contract manufacturers providing micronization of active ingredients for the pharmaceutical and fine chemical industries
veterinary drug

CordenPharma invests €10 million into new manufacturing line

CordenPharma Plankstadt announced the design and installment of a new manufacturing line dedicated to producing Veterinary Drug Products

Eli Lilly aquired R&D platform from Adimab

Adimab LLC, a global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that it has entered into an agreement with Eli Lilly

Daiichi Sankyo will collaborate with Max Planck Innovation and Lead Discovery Center

Daiichi Sankyo, Max Planck Innovation GmbH and the Lead Discovery Center GmbH have signed an agreement providing Daiichi Sankyo with the option to receive the exclusive rights to a new lead compound for the treatment of cancer

FSBI SCEEMP and SECMED define the areas for their cooperation

The first meeting of CECMED and FSBI SCEEMP took place during the First Russian-Cuban Medical and Pharmaceutical Business Forum

Market share of Russian-made drugs exceeds 80% for some nosologies

In 2016, the market share of Russian-made medicinal products in the segment of anti-tuberculosis drugs was 76%

MSD and R-Pharm invested 200 million rubles in the localization of Raltegravir

MSD, an international biopharmaceutical company, and R-Pharm, a leading Russian pharmaceutical company, have announced the successful completion of their joint project

Contact Manufacturing Companies